Cancer drug row puts greed before need

Cancer drug row puts greed before need

‘The row over drugs pricing this week may have wiped six months off the lives of 1,500 women.
Kadcyla, a drug to treat an aggressive type of breast cancer, has been deemed too expensive for the NHS.
The price that its manufacturers, Roche, were charging has not been disclosed—though they began talks by demanding £90,000 per patient.
Pharmaceutical giants have turned the holding of seriously ill people to ransom into something of an art form.’
Read more: Cancer drug row puts greed before need